Does a negative blood PCR rule out Lyme borreliosis?

Lyme borreliosis can involve only transient, sparse bloodstream dissemination, while later infection tends to be more tissue-localized. Consequently, blood PCR detects circulating Borrelia DNA rather than reliably determining whether Lyme disease is present.

Clinical evidence

• A negative blood Borrelia PCR does not exclude Lyme borreliosis. Reported sensitivity in early disease is commonly only ~30–50%; across studies/meta-analytic evidence, estimates span ~33.8–62%, with one broader review reporting a median of 14%.
• Performance is particularly poor in suspected neuroborreliosis, with reported blood-PCR sensitivity of approximately 1–28%. These sensitivities imply frequent false-negative results, making blood PCR unsuitable as a stand-alone rule-out test.
• Diagnostic testing should follow the presentation. Typical erythema migrans is principally a clinical diagnosis. When laboratory testing is warranted, serum antibody testing is generally preferred; in selected seropositive patients with suspected Lyme arthritis, synovial-fluid or tissue PCR may be more informative than blood PCR.

Mechanistic explanation

• Sparse, stage-dependent spirochetemia means that circulating DNA may be below the assay’s detection threshold, especially after the earliest disseminative phase as organisms become more tissue-localized.
• Detection is also affected by sampled blood volume, the blood fraction tested, and assay methodology; plasma may outperform serum or whole blood, and larger input volumes can improve recovery. Thus, a negative result can reflect sampling and analytic constraints rather than absence of infection.
• Conversely, detectable DNA after antibiotic treatment may represent residual nucleic acid and does not by itself demonstrate viable organisms or treatment failure.

Bottom line

• The claim is well supported: low and transient blood levels of Borrelia DNA make blood PCR insensitive and strongly dependent on disease stage. For this 77-year-old man, a negative blood PCR should not be used to dismiss clinically plausible Lyme borreliosis; interpretation requires symptoms, timing, examination findings, and appropriately targeted testing.